Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016, until now no-one has managed to get the FDA to approve a cheaper copy of the drug-device ...

Hikma's filing for a generic version of GlaxoSmithKline's Advair Diskus has been accepted by the ... performance in 2015 – a year that saw a 30% decrease in generics revenue compared to 2014.

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... twice daily from a Diskus™ inhaler for a 4-week ...